omeprazole and glucagon-like peptide 1

omeprazole has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahekar, R; Detroja, J; Dhanesha, N; Gandhi, T; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V	1

Other Studies

1 other study(ies) available for omeprazole and glucagon-like peptide 1

Article	Year
Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice. Pharmacological reports : PR, 2013, Volume: 65, Issue:4 Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice; NF-E2-Related Factor 2; Omeprazole; Peptides; Proton Pump Inhibitors; Venoms	2013

Article

Year

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.

Pharmacological reports : PR, 2013, Volume: 65, Issue:4

Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice; NF-E2-Related Factor 2; Omeprazole; Peptides; Proton Pump Inhibitors; Venoms

2013